Dyadic International (DYAI) Convertible Debt (2024 - 2026)
Dyadic International (DYAI) posted Convertible Debt of $3.0 million for Q1 2026, little changed sequentially from $3.0 million in Q4 2025, and down 24.33% YoY from $3.9 million in Q1 2025.
Dyadic International (DYAI) Convertible Debt (2024 - 2026) Analysis & Trends
Dyadic International has reported Convertible Debt for 3 years, with the latest figure at $3.0 million in Q1 2026.
- Quarterly Convertible Debt fell 24.33% year-over-year to $3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.0 million (down 24.33% YoY) and the FY2025 annual result came in at $3.0 million, up 177.92% from the prior year.
- Convertible Debt was little changed at $3.0 million in Q1 2026 per DYAI's latest filing, from $3.0 million in the prior quarter.
- Over five years, Convertible Debt peaked at $3.9 million in Q1 2025 and troughed at $1.1 million in Q4 2024.
- A 3-year average of $2.6 million and a median of $3.0 million in 2025 frame the typical range for Convertible Debt.
- The widest YoY moves for Convertible Debt: up 177.92% in 2025, down 72.49% in 2025.
- Over 3 years, Convertible Debt stood at $1.1 million in 2024, then soared by 177.92% to $3.0 million in 2025, then gained by 0.15% to $3.0 million in 2026.
- According to Business Quant data, Convertible Debt over the past three periods registered $3.0 million, $3.0 million, and $2.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Dyadic International | 19.98 Mn | 19.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.97 Mn |
| Dec 31, 2025 | 2.96 Mn |
| Sep 30, 2025 | 2.06 Mn |
| Jun 30, 2025 | 1.07 Mn |
| Mar 31, 2025 | 3.92 Mn |
| Dec 31, 2024 | 1.07 Mn |
| Sep 30, 2024 | 1.37 Mn |
| Jun 30, 2024 | 3.89 Mn |
| Mar 31, 2024 | 3.88 Mn |